Sjekkpunkthemmere og nevrologiske bivirkninger
Sist oppdatert: Publisert:
Sist revidert av:Åse Mygland
- Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, Rogemond V, Marchal C, Chiappa AM, Chanson E, Skowron F, Leblanc A, Ducray F, Honnorat J. Central nervous system complications associated with immune checkpoint inhibitors. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):772-778. doi: 10.1136/jnnp-2020-323055. Epub 2020 Apr 20. PMID: 32312871. PubMed
- Damato V, Berretta A, Ramanathan S, Michael S, Coupe N, Payne M, Irani SR. Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors. JAMA Neurol. 2022 Sep 1;79(9):949-951. doi: 10.1001/jamaneurol.2022.1824. PMID: 35816342 PubMed
- Vogrig A, Muñiz-Castrillo S, Farina A, Honnorat J, Joubert B. How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update. J Neurol. 2021 Oct 27. doi: 10.1007/s00415-021-10870-6. Epub ahead of print. PMID: 34708250. PubMed
- Velasco R, Villagrán M, Jové M, Simó M, Vilariño N, Alemany M, Palmero R, Martínez-Villacampa MM, Nadal E, Bruna J. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review. JAMA Neurol. 2021 Jul 1;78(7):864-873. doi: 10.1001/jamaneurol.2021.0249. PMID: 33720308.
- Åse Mygland, spesialist i nevrologi, professor, dr med
- Unn Ljøstad, spesialist i nevrologi, professor, PhD